Search

everythinglearnresearchcommunity

for

Search:↓

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Targeting Vδ1+T-cells may help treat alopecia areata.

Hair loss from alopecia areata can rarely be caused by dental problems, and treating the dental issue may reverse the hair loss.

There's no significant relationship between hair loss (androgenetic alopecia) and demodex infestation.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Melatonin reduced oxidative stress and might improve hair growth in alopecia areata patients.

New small molecule drugs could help treat hair loss.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Apremilast may help treat hair loss in alopecia areata.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Low serum levels of zinc and selenium may increase the risk of alopecia areata.

New therapies for alopecia areata show potential but need more research.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Mice with alopecia areata had wider lymphatic vessels in their skin.

Toxic metals can cause hair loss and should be considered by doctors.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.